CR20170439A - Formas cristalinas de un compuesto de pirrolopiridina - Google Patents

Formas cristalinas de un compuesto de pirrolopiridina

Info

Publication number
CR20170439A
CR20170439A CR20170439A CR20170439A CR20170439A CR 20170439 A CR20170439 A CR 20170439A CR 20170439 A CR20170439 A CR 20170439A CR 20170439 A CR20170439 A CR 20170439A CR 20170439 A CR20170439 A CR 20170439A
Authority
CR
Costa Rica
Prior art keywords
pirrolopiridine
compound
crystal forms
aminopiperidin
cyclopropanecarboxamide
Prior art date
Application number
CR20170439A
Other languages
English (en)
Inventor
Christopher M Lindemann
Weidong Liu
Keith L Spencer
Jeffrey Stults
Joseph Lubach
Original Assignee
Array Biopharma Inc
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55521844&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20170439(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Array Biopharma Inc, Genentech Inc filed Critical Array Biopharma Inc
Publication of CR20170439A publication Critical patent/CR20170439A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describen formas cristalinas de (R)-N-(4-(3-aminopiperidin-1-il)-5-bromo-1H-pirrolo[2,3-b]piridin-3-il)ciclopropanocarboxamida, y solvatos, hidratos y sales de estas, y composiciones farmacéuticas, formulaciones y un proceso para confeccionarlos.
CR20170439A 2015-02-26 2016-02-26 Formas cristalinas de un compuesto de pirrolopiridina CR20170439A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562121396P 2015-02-26 2015-02-26
PCT/US2016/019904 WO2016138458A1 (en) 2015-02-26 2016-02-26 Crystalline forms of a pyrrolopyridine compound

Publications (1)

Publication Number Publication Date
CR20170439A true CR20170439A (es) 2018-01-08

Family

ID=55521844

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20170439A CR20170439A (es) 2015-02-26 2016-02-26 Formas cristalinas de un compuesto de pirrolopiridina

Country Status (21)

Country Link
US (2) US20160251350A1 (es)
EP (1) EP3262042A1 (es)
JP (1) JP2018506562A (es)
KR (1) KR20170118762A (es)
CN (1) CN107406447A (es)
AR (1) AR103801A1 (es)
AU (1) AU2016225070A1 (es)
BR (1) BR112017018230A2 (es)
CA (1) CA2976665A1 (es)
CL (1) CL2017002180A1 (es)
CO (1) CO2017009662A2 (es)
CR (1) CR20170439A (es)
HK (1) HK1246786A1 (es)
IL (1) IL254115A0 (es)
MA (1) MA41599A (es)
MX (1) MX2017010888A (es)
PE (1) PE20171327A1 (es)
PH (1) PH12017501532A1 (es)
RU (1) RU2017133093A (es)
SG (1) SG11201706824TA (es)
WO (1) WO2016138458A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112638903B (zh) * 2019-01-29 2022-08-26 沪亚生物国际有限公司 舒欣啶盐
EP3923948A4 (en) * 2019-02-12 2022-11-16 Impact Biomedicines, Inc. CRYSTALLINE SHAPES OF A JAK2 INHIBITOR

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
CL2009001152A1 (es) * 2008-05-13 2009-10-16 Array Biopharma Inc Compuestos derivados de n-(4-(cicloalquilo nitrogenado-1-il)-1h-pirrolo[2,3-b]piridin-3-il)amida, inhibidores de cinasa; proceso de preparacion; composicion farmaceutica; y su uso para el tratamiento de una enfermedad proliferativa.
US8481557B2 (en) * 2009-04-11 2013-07-09 Array Biopharma Inc. Method of treatment using checkpoint kinase 1 inhibitors
RU2017127088A (ru) * 2010-11-16 2019-02-04 Эррэй Биофарма Инк. Комбинация ингибиторов чекпойнт-киназы 1 и ингибиторов киназы wee 1
WO2015027090A1 (en) * 2013-08-22 2015-02-26 Genentech, Inc. Intermediates and processes for preparing compounds
CA2921956C (en) * 2013-08-22 2021-10-19 Genentech, Inc. Process for preparing (r)-5-bromo-4-(3-amino)piperidin-1-yl)-3-(cyclopropanecarboxamido)-1h-pyrrolo[2,3-b]pyridine

Also Published As

Publication number Publication date
CN107406447A (zh) 2017-11-28
PH12017501532A1 (en) 2018-02-05
JP2018506562A (ja) 2018-03-08
WO2016138458A1 (en) 2016-09-01
CO2017009662A2 (es) 2018-02-28
MA41599A (fr) 2018-01-02
CL2017002180A1 (es) 2018-03-16
RU2017133093A3 (es) 2019-08-23
CA2976665A1 (en) 2016-09-01
AU2016225070A1 (en) 2017-09-07
US20180282324A1 (en) 2018-10-04
AR103801A1 (es) 2017-06-07
SG11201706824TA (en) 2017-09-28
RU2017133093A (ru) 2019-03-26
HK1246786A1 (zh) 2018-09-14
BR112017018230A2 (pt) 2018-04-17
PE20171327A1 (es) 2017-09-12
EP3262042A1 (en) 2018-01-03
KR20170118762A (ko) 2017-10-25
US20160251350A1 (en) 2016-09-01
IL254115A0 (en) 2017-10-31
MX2017010888A (es) 2017-12-15

Similar Documents

Publication Publication Date Title
SV2017005467A (es) Formas sólidas de un inhibidor ask1.
SI3494115T1 (sl) Derivati N-(fenilsulfonil)benzamida kot BCL-2 inhibitorji
DK3529241T3 (da) Pireridinderivater som inhibitorer af ubiquitin-specifik protease 7
GEP20207074B (en) New hydroxyester derivatives, a process for their preparation and pharmaceutical compositions containing them
CL2017000979A1 (es) Formas cristalinas de 5-cloro-n4-[2-(dimetilfosforil)fenil]-n2-{2-metoxi-4-[4-(4-metilpiperazin-1-il)piperidin-1-il]pirimidina-2,4-diamina
BR112017013491A2 (pt) compostos de pirimidina fundida para o tratamento de hiv
PE20160287A1 (es) Inhibidores cristalinos de bromodominos
DK3385262T3 (da) 4-(3h-indol-5-yl)-n-(pyridin-2-yl)pyrimidin-2-aminderivater som proteinkinaseinhibitorer, fremstillingsfremgangsmåde og medicinsk anvendelse deraf
DK3412672T3 (da) Krystalform A af 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-D]pyrimidin-4-amin som TLR7-agonist, fremstillingsfremgangsmåde og anvendelse deraf
CL2017002354A1 (es) Compuestos derivados de heteroarilos bicíclicos fusionados con actividad como inhibidores de phd.
UY35535A (es) ?Derivados de fenil sulfonamidas?.
DK3797107T3 (da) Heterokondenserede pyridonforbindelser og anvendelse deraf som idh- hæmmere
IL276430A (en) A pharmaceutical compound, its cures, its formulations, and methods for its preparation and use
CY1125052T1 (el) Κρυσταλλικες μορφες
DK3634968T3 (da) Heterocykliske forbindelser, der kan anvendes som antibakterielle midler, og fremgangsmåde til fremstilling heraf
UY35536A (es) ?derivados de sulfonamida?.
IL274737A (en) Novel piperidinyls as inhibitors of ubiquitin-specific protease 7
DK3873894T3 (da) Hidtil ukendt salt af en bcl-2-hæmmer, relateret krystallisk form, fremgangsmåde til fremstilling af samme og farmaceutiske sammensætninger, der indeholder samme
CO2017009662A2 (es) Formas cristalinas de un compuesto de pirrolopiridina
IL283656A (en) New crystalline forms of mcl-1 inhibitor, process for their preparation and pharmaceutical preparations containing them
DOP2018000032A (es) Composición herbicida y proceso para prepararla
DK3398946T3 (da) Salt af morpholin-derivat og krystallin form deraf, samt fremstillingsfremgangsmåde, farmaceutisk sammensætning og anvendelse af samme
BR112018013356A2 (pt) sal de cloridrato, formas cristalinas de um sal de cloridrato e composição farmacêutica
BR112016024521A2 (pt) sais e polimorfos de um composto imidazopiridinil-aminopiridina
UY36464A (es) Compuestos de quinazolina